MX9303244A - Plaquetas de sangre humana fijadas-secadas, farmaceuticamente aceptables. - Google Patents
Plaquetas de sangre humana fijadas-secadas, farmaceuticamente aceptables.Info
- Publication number
- MX9303244A MX9303244A MX9303244A MX9303244A MX9303244A MX 9303244 A MX9303244 A MX 9303244A MX 9303244 A MX9303244 A MX 9303244A MX 9303244 A MX9303244 A MX 9303244A MX 9303244 A MX9303244 A MX 9303244A
- Authority
- MX
- Mexico
- Prior art keywords
- fixed
- platelets
- human blood
- pharmaceutically
- adhere
- Prior art date
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 210000001772 blood platelet Anatomy 0.000 abstract 4
- 230000002885 thrombogenetic effect Effects 0.000 abstract 3
- 239000000834 fixative Substances 0.000 abstract 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 abstract 1
- 229930040373 Paraformaldehyde Natural products 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 230000002439 hemostatic effect Effects 0.000 abstract 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001453 nonthrombogenic effect Effects 0.000 abstract 1
- 229920002866 paraformaldehyde Polymers 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
Abstract
Se describen plaquetas de sangre humana fijadas-secadas y procedimientopara preparar las mismas. Las plaquetas, después de reconstrucción: seadhieren a la superficies trombogénicas; no se adhieren a superficies notrombogénicas; sufren cambio de forma (extendimiento) después de adherirsea una superficie trombogénica; se adhieren entre sí para formar un tapónhemostático después de adherirse a una superficie trombogénica; y liberansus contenidos granulares. Se describen también composicionesfarmacéuticas que contienen a las mismas. las plaquetas se fijanpreferiblemente por medio de un fijador tal como formaldehído,paraformaldehído, o glutaraldehído, o se fijan por medio de un fijador depermanganato. Las plaquetas se secan preferiblemente por liofilización.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89127792A | 1992-05-29 | 1992-05-29 | |
PCT/US1993/004142 WO1993023997A1 (en) | 1992-05-29 | 1993-04-28 | Pharmaceutically acceptable fixed-dried human blood platelets |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9303244A true MX9303244A (es) | 1995-01-31 |
Family
ID=25397895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9303244A MX9303244A (es) | 1992-05-29 | 1993-04-28 | Plaquetas de sangre humana fijadas-secadas, farmaceuticamente aceptables. |
Country Status (15)
Country | Link |
---|---|
US (3) | US5651966A (es) |
EP (2) | EP0642301B1 (es) |
JP (1) | JP4445589B2 (es) |
AT (2) | ATE311438T1 (es) |
AU (1) | AU680612B2 (es) |
BR (1) | BR9306443A (es) |
CA (1) | CA2136848C (es) |
DE (2) | DE69332756T2 (es) |
DK (1) | DK0642301T3 (es) |
ES (2) | ES2194013T3 (es) |
HK (1) | HK1058376A1 (es) |
MX (1) | MX9303244A (es) |
PT (1) | PT642301E (es) |
RU (1) | RU2126259C1 (es) |
WO (1) | WO1993023997A1 (es) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023997A1 (en) * | 1992-05-29 | 1993-12-09 | The University Of North Carolina At Chapel Hill | Pharmaceutically acceptable fixed-dried human blood platelets |
AR001654A1 (es) * | 1995-04-19 | 1997-11-26 | Univ East Carolina | Método para la descontaminacion microbiana de plaquetas sanguineas |
US5891393A (en) * | 1996-04-09 | 1999-04-06 | The University Of North Carolina At Chapel Hill | Method for the microbial decontamination of blood platelets |
DE19634313A1 (de) * | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Methode zur Stabilisierung von Plättchen |
DE69810755T2 (de) * | 1997-02-07 | 2003-08-07 | Elan Drug Delivery Ltd., Ruddington | Verfahren und zusammensetzungen zur herstellung getrockneter, lagerungsstabiler blutplättchen |
AT407484B (de) | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
US6139878A (en) * | 1998-04-27 | 2000-10-31 | Aventis Behring, Llc | Method for preparing a diafiltered stabilized blood product |
EP1232753B1 (en) * | 1999-09-08 | 2008-03-19 | Chugai Seiyaku Kabushiki Kaisha | Stable protein solution filled in a container made from a hydrophobic resin and method of stabilizing the same |
WO2001058266A1 (en) * | 2000-02-10 | 2001-08-16 | The Regents Of The University Of California | Therapeutic platelets and methods |
US6770478B2 (en) | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
US20020141964A1 (en) * | 2001-01-19 | 2002-10-03 | Patterson James A. | Composition for arresting the flow of blood and method |
US6653062B1 (en) * | 2000-07-26 | 2003-11-25 | Wisconsin Alumni Research Foundation | Preservation and storage medium for biological materials |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
US6673603B2 (en) | 2000-09-01 | 2004-01-06 | Modex Therapeutiques, S.A. | Cell paste comprising keratinocytes and fibroblasts |
ES2173812B1 (es) * | 2001-03-01 | 2003-12-16 | Ct Investig Energeticas Ciemat | Dermis artificial y metodo de obtencion. |
JP4289886B2 (ja) * | 2001-05-09 | 2009-07-01 | バイオインターラクションズ リミテッド | 創傷閉鎖システム及び方法 |
US20030104386A1 (en) * | 2001-08-31 | 2003-06-05 | The Regents Of The University Of California | Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and DNA sequencing |
US6884573B2 (en) * | 2001-08-31 | 2005-04-26 | The University Of North Carolina At Chapel Hill | Fixed dried red blood cells and method of use |
US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
US6811777B2 (en) | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
WO2004011616A2 (en) * | 2002-07-26 | 2004-02-05 | The General Hospital Corporation | Systems and methods for cell preservation |
US7294455B2 (en) * | 2003-05-16 | 2007-11-13 | The University Of North Carolina At Chapel Hill | Fixed-dried platelets cross-linked to protein |
TW200505394A (en) * | 2003-06-06 | 2005-02-16 | Asahi Medical Co | Material promoting wound healing |
JP5183068B2 (ja) * | 2003-12-22 | 2013-04-17 | フィンレイ,ウォーレン,エイチ | 大気噴出凍結乾燥法による粉末形成 |
WO2005065269A2 (en) * | 2003-12-29 | 2005-07-21 | Am Biosolutions | Compositions and method for decreasing the appearance of skin wrinkles |
US20050191286A1 (en) * | 2004-02-09 | 2005-09-01 | Gandy James B. | Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair |
US20060142198A1 (en) * | 2004-07-02 | 2006-06-29 | Wound Care Partners Llc | Compositions for treating wounds and processes for their preparation |
US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
EP1784639B1 (en) | 2004-08-12 | 2010-01-20 | CELLPHIRE, Inc. | Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use |
US7811558B2 (en) * | 2004-08-12 | 2010-10-12 | Cellphire, Inc. | Use of stabilized platelets as hemostatic agent |
US20060035383A1 (en) * | 2004-08-12 | 2006-02-16 | David Ho | Dry platelet preparations for use in diagnostics |
US7462268B2 (en) * | 2004-08-20 | 2008-12-09 | Allan Mishra | Particle/cell separation device and compositions |
WO2008048229A2 (en) * | 2005-08-12 | 2008-04-24 | Department Of The Army | Stabilized lyophilized blood platelets |
CA2623666C (en) * | 2005-09-26 | 2017-10-24 | Lifecell Corporation | Dry platelet composition |
US8920827B2 (en) | 2005-10-21 | 2014-12-30 | Wake Forest University Health Sciences | Keratin bioceramic compositions |
US8277837B2 (en) * | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
US8097403B2 (en) * | 2006-12-14 | 2012-01-17 | Cellphire, Inc. | Freeze-dried platelets, method of making and method of use as a diagnostic agent |
US8052969B2 (en) * | 2006-12-28 | 2011-11-08 | Arthrex, Inc. | Method of making plasma enriched with platelets using a double syringe system where the second sytringe is within the first syringe and use thereof |
US20090053288A1 (en) * | 2007-08-20 | 2009-02-26 | Eskridge Jr E Stan | Hemostatic woven fabric |
WO2009052221A2 (en) * | 2007-10-15 | 2009-04-23 | The Regents Of The University Of Colorado | Methods for extracting platelets and compositions obtained therefrom |
US8835104B2 (en) | 2007-12-20 | 2014-09-16 | Fenwal, Inc. | Medium and methods for the storage of platelets |
WO2010042658A1 (en) | 2008-10-07 | 2010-04-15 | Bioparadox, Llc | Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
WO2010042762A1 (en) * | 2008-10-09 | 2010-04-15 | Bioparadox, Llc | Platelet rich plasma formulations for cardiac treatments |
US20100233282A1 (en) * | 2009-03-13 | 2010-09-16 | Allan Mishra | Device and methods for delivery of bioactive materials to the right side of the heart |
US9867782B2 (en) | 2009-04-09 | 2018-01-16 | Entegrion, Inc. | Spray-dried blood products and methods of making same |
US8407912B2 (en) | 2010-09-16 | 2013-04-02 | Velico Medical, Inc. | Spray dried human plasma |
WO2011035062A2 (en) | 2009-09-16 | 2011-03-24 | Velico Medical, Inc. | Spray dried human plasma |
US20110183311A1 (en) * | 2010-01-27 | 2011-07-28 | David Ho | Dry platelet preparations for use in diagnostics |
US8777986B2 (en) * | 2010-05-05 | 2014-07-15 | Ethicon, Inc. | Incision guide and wound closure device and methods therefor |
US20140083628A1 (en) | 2012-09-27 | 2014-03-27 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
CN103338849A (zh) | 2010-10-29 | 2013-10-02 | 维利科医学公司 | 用于对液体进行喷雾干燥的系统和方法 |
US9427360B2 (en) | 2010-11-04 | 2016-08-30 | W. Jerry Mezger | Hemostatic fabric |
AU2011329839B2 (en) | 2010-11-17 | 2016-12-08 | Wake Forest University Health Sciences | Keratin compositions for treatment of bone deficiency or injury |
US9402866B2 (en) | 2011-04-07 | 2016-08-02 | Fenwal, Inc. | Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates |
US9700631B2 (en) | 2011-08-17 | 2017-07-11 | KeraNetics, LLC | Low protein percentage gelling compositions |
EP2744820B1 (en) | 2011-08-17 | 2018-07-25 | Keranetics LLC | Methods for extracting keratin proteins |
GB201201751D0 (en) | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
RU2506946C1 (ru) * | 2012-11-28 | 2014-02-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации | Технология лиофилизации обогащенной тромбоцитами плазмы с сохранением жизнеспособности факторов tgf pdgf vegf |
US9827245B2 (en) | 2013-03-15 | 2017-11-28 | KeraNetics, LLC | Keratin compositions comprising halofuginone |
US20140356893A1 (en) | 2013-06-04 | 2014-12-04 | Allan Mishra | Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation |
US10406255B2 (en) | 2014-05-28 | 2019-09-10 | Highland Industries, Inc. | Hemostatic textile |
US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
WO2019055683A1 (en) * | 2017-09-13 | 2019-03-21 | Hale Anne S | CANINE BLOOD PLATELET PREPARATIONS |
CA3078625C (en) | 2017-10-09 | 2023-01-17 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
EP3887402A4 (en) | 2018-11-30 | 2022-10-26 | Cellphire, Inc. | PLATES USED AS ADMINISTRATION AGENTS |
EP3886879A4 (en) | 2018-11-30 | 2022-12-07 | Cellphire Inc. | PLATES AS DELIVERY AGENTS |
WO2020185916A1 (en) | 2019-03-14 | 2020-09-17 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
AU2020267368B2 (en) | 2019-05-03 | 2023-05-04 | Cellphire, Inc. | Materials and methods for producing blood products |
US20210308066A1 (en) | 2020-02-04 | 2021-10-07 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
CN114450066A (zh) | 2019-08-16 | 2022-05-06 | 塞尔菲乐有限公司 | 作为抗血小板剂逆转剂的血栓小体 |
US11998861B2 (en) | 2022-09-15 | 2024-06-04 | Velico Medical, Inc. | Usability of a disposable for a spray drying plasma system |
US12083447B2 (en) | 2022-09-15 | 2024-09-10 | Velico Medical, Inc. | Alignment of a disposable for a spray drying plasma system |
US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
US11975274B2 (en) | 2022-09-15 | 2024-05-07 | Velico Medical, Inc. | Blood plasma product |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2546166A1 (de) * | 1975-10-15 | 1977-04-28 | Behringwerke Ag | Gegerbte thrombozyten |
US4145185A (en) * | 1977-02-25 | 1979-03-20 | Research Triangle Institute | Reagents for screening tests and bioassay of von Willebrand's factor (platelet aggregating factor) in blood plasmas |
US4287087A (en) * | 1977-02-25 | 1981-09-01 | Research Triangle Institute | Fixed-dried blood platelets |
US4302355A (en) * | 1977-08-01 | 1981-11-24 | Warner-Lambert Company | Platelet reference control |
US4199954A (en) * | 1978-08-09 | 1980-04-29 | American National Red Cross | Method of storing physiological material |
DE3141894A1 (de) * | 1981-10-22 | 1983-05-05 | Behringwerke Ag, 3550 Marburg | Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) |
US4605413A (en) * | 1983-09-19 | 1986-08-12 | The University Of Alabama At Birmingham | Stimulation of chemotaxis by chemotactic peptides |
US4717654A (en) * | 1984-06-19 | 1988-01-05 | Akzo N.V. | Process for solid phase platelet antibody assay |
US5165938A (en) * | 1984-11-29 | 1992-11-24 | Regents Of The University Of Minnesota | Wound healing agents derived from platelets |
US4695460A (en) * | 1986-03-19 | 1987-09-22 | American Red Cross | Synthetic, plasma-free, transfusible platelet storage medium |
US5248506A (en) * | 1986-03-19 | 1993-09-28 | American National Red Cross | Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets |
DK475386D0 (da) * | 1986-10-03 | 1986-10-03 | Weis Fogh Ulla Sivertsen | Fremgangsmaade og apparat til fremstilling af biologiske stoffer |
US4764463A (en) * | 1986-10-30 | 1988-08-16 | The University Of Tennessee Research Corporation | Platelet cyropreservation |
US4880788A (en) * | 1987-10-30 | 1989-11-14 | Baylor College Of Medicine | Method for preventing and treating thrombosis |
US5043261A (en) * | 1989-04-10 | 1991-08-27 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell and hemosome compositions |
US5213814A (en) * | 1989-04-10 | 1993-05-25 | Cryopharm Corporation | Lyophilized and reconstituted blood platelet compositions |
US4994367A (en) * | 1988-10-07 | 1991-02-19 | East Carolina University | Extended shelf life platelet preparations and process for preparing the same |
US5059518A (en) * | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
US5030560A (en) * | 1988-11-04 | 1991-07-09 | Immucor, Inc. | Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5428008A (en) * | 1989-04-14 | 1995-06-27 | Prp, Inc. | Therapeutic composition of micellar structures capable of promoting hemotasis |
US5328840A (en) * | 1989-08-15 | 1994-07-12 | The Research Foundation Of The State University Of New York | Method for preparing targeted carrier erythrocytes |
US5236716A (en) * | 1990-02-12 | 1993-08-17 | Miles Inc. | Platelets concentrate with low white blood cells content |
US5151360A (en) * | 1990-12-31 | 1992-09-29 | Biomembrane Institute | Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation |
US5376524A (en) * | 1991-04-01 | 1994-12-27 | Thomas Jefferson University | Platelet storage medium containing acetate and phosphate |
US5344752A (en) * | 1991-10-30 | 1994-09-06 | Thomas Jefferson University | Plasma-based platelet concentrate preparations |
US5260066A (en) * | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
WO1993023997A1 (en) * | 1992-05-29 | 1993-12-09 | The University Of North Carolina At Chapel Hill | Pharmaceutically acceptable fixed-dried human blood platelets |
US5378601A (en) * | 1992-07-24 | 1995-01-03 | Montefiore Medical Center | Method of preserving platelets with apyrase and an antioxidant |
US5358844A (en) * | 1993-02-18 | 1994-10-25 | Brigham And Women's Hospital, Inc. | Preservation of blood platelets |
-
1993
- 1993-04-28 WO PCT/US1993/004142 patent/WO1993023997A1/en active IP Right Grant
- 1993-04-28 EP EP93910993A patent/EP0642301B1/en not_active Expired - Lifetime
- 1993-04-28 JP JP50054494A patent/JP4445589B2/ja not_active Expired - Fee Related
- 1993-04-28 CA CA002136848A patent/CA2136848C/en not_active Expired - Lifetime
- 1993-04-28 EP EP03000701A patent/EP1338648B1/en not_active Expired - Lifetime
- 1993-04-28 DE DE69332756T patent/DE69332756T2/de not_active Expired - Lifetime
- 1993-04-28 PT PT93910993T patent/PT642301E/pt unknown
- 1993-04-28 US US08/325,424 patent/US5651966A/en not_active Expired - Lifetime
- 1993-04-28 MX MX9303244A patent/MX9303244A/es unknown
- 1993-04-28 DE DE69333924T patent/DE69333924T2/de not_active Expired - Lifetime
- 1993-04-28 AU AU42295/93A patent/AU680612B2/en not_active Ceased
- 1993-04-28 AT AT03000701T patent/ATE311438T1/de active
- 1993-04-28 ES ES93910993T patent/ES2194013T3/es not_active Expired - Lifetime
- 1993-04-28 BR BR9306443A patent/BR9306443A/pt not_active Application Discontinuation
- 1993-04-28 DK DK93910993T patent/DK0642301T3/da active
- 1993-04-28 AT AT93910993T patent/ATE234003T1/de not_active IP Right Cessation
- 1993-04-28 RU RU94046415/14A patent/RU2126259C1/ru not_active IP Right Cessation
- 1993-04-28 ES ES03000701T patent/ES2254795T3/es not_active Expired - Lifetime
-
1996
- 1996-12-31 US US08/775,287 patent/US5902608A/en not_active Expired - Lifetime
- 1996-12-31 US US08/775,413 patent/US5993804A/en not_active Expired - Lifetime
-
2004
- 2004-02-13 HK HK04100979A patent/HK1058376A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2126259C1 (ru) | 1999-02-20 |
US5651966A (en) | 1997-07-29 |
EP0642301A1 (en) | 1995-03-15 |
ES2254795T3 (es) | 2006-06-16 |
JP4445589B2 (ja) | 2010-04-07 |
EP1338648B1 (en) | 2005-11-30 |
US5902608A (en) | 1999-05-11 |
CA2136848A1 (en) | 1993-12-09 |
ES2194013T3 (es) | 2003-11-16 |
DE69332756T2 (de) | 2004-02-19 |
AU680612B2 (en) | 1997-08-07 |
HK1058376A1 (en) | 2004-05-14 |
WO1993023997A1 (en) | 1993-12-09 |
BR9306443A (pt) | 1998-06-30 |
EP0642301B1 (en) | 2003-03-12 |
DK0642301T3 (da) | 2003-06-23 |
PT642301E (pt) | 2003-06-30 |
RU94046415A (ru) | 1996-10-10 |
CA2136848C (en) | 2008-07-08 |
ATE234003T1 (de) | 2003-03-15 |
AU4229593A (en) | 1993-12-30 |
DE69333924D1 (de) | 2006-01-05 |
DE69333924T2 (de) | 2006-08-17 |
EP1338648A1 (en) | 2003-08-27 |
US5993804A (en) | 1999-11-30 |
ATE311438T1 (de) | 2005-12-15 |
EP0642301A4 (en) | 1998-05-06 |
DE69332756D1 (de) | 2003-04-17 |
JPH07507304A (ja) | 1995-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9303244A (es) | Plaquetas de sangre humana fijadas-secadas, farmaceuticamente aceptables. | |
IT8848714A0 (it) | Derivati di adenosina, composizioni farmaceutiche che li contengono erelativo procedimento di preparazione ed appplicazione | |
DK52382A (da) | Fremgangsmaade til fremstilling af keramsike formlegemer paa basis af tricalciumphosphat specielt til udfyldning af hulrum eller til sammensaetning af knogledele efeter fraktur | |
IT1172229B (it) | Oligomeri tensioattivi, procentimento per la loro preparazione e composizioni che li contengono | |
MX9203394A (es) | Benzazepinas substituidas, su preparacion y composiciones farmaceuticas que contienen las mismas. | |
ES501934A0 (es) | Un procedimiento para la preparacion de una fibra de alginato. | |
ATE7228T1 (de) | Imidazolinderivat, dessen salze, verfahren zur herstellung und dessen pharmazeutische zusammensetzungen. | |
IT1205715B (it) | Derivati di piroglutammide,agenti nootropici che li contengono e procedimento per la loro preparazione | |
IT1205665B (it) | Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
MX5959E (es) | Procedimiento para la preparacion de composiciones farmaceuticas estables que contiene quelatos de oxitetraciclina,magnesio y calcio,en una solucion de 2-pirrolidona acuosa | |
IT7948011A0 (it) | Procedimento per la preparazione di derivati di 2-fenilimminoimidazolidine composizioni farmaceutiche che li contengono e prodotto ottenuto | |
IT8319027A0 (it) | Derivati amino-alchil-solfonici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT9021305A0 (it) | Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono | |
MX161254A (es) | Procedimiento mejorado para la fabricacion y colocacion previa,antes de la sujecion definitiva,de las lineas de una plataforma de lineas tendidas | |
DE68919887D1 (de) | Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer. | |
IT8448800A0 (it) | Amminociclopentani, composizioni farmaceutiche che li contengono eprocedimento per la loro preparazione | |
IT1167820B (it) | Derivati del benzossazolone,procedimenti per la preparazione di questi e composizioni che li contengono | |
IT8922275A0 (it) | Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT8621837A0 (it) | Nuovi derivati biciclici del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono. | |
IT8520483A0 (it) | Derivati di apovincaminolo, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT8548819A0 (it) | Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli | |
IT8123540A0 (it) | Procedimento per la preparazione di composti citostatici e composizioni farmaceutiche contenenti gli stessi. | |
MX6790E (es) | Procedimiento para la preparacion de una composicion desinfectante topica que comprende complejo de polivinilpirrolidona-yodo en particulas | |
MX11486A (es) | Procedimiento para la preparacion de una composicion farmaceutica y composicion obtenida. | |
IT8323462A0 (it) | Sale di s-adenosil-l-metionina, composizione contenente tale sale preferibilmente per uso farmaceutico e procedimento di preparazione. |